Clinical Studies in Diabetic Nephropathy : NIDDK

Clinical Studies in Diabetic Nephropathy

The Diabetic Kidney Disease Program funds basic research on the pathophysiology and pathogenesis of diabetic nephropathy, natural history studies, and clinical trials through the R01 mechanism. Fundamental research focuses on the molecular pathogenesis of extracellular matrix expansion and glomerulosclerosis, the role of the renin-angiotension system and growth factors, and the identification of treatments to prevent renal scarring.

Of special interest are studies to understand the mechanisms of progressive renal scarring, to identify genes that either protect people from or predispose them to diabetic nephropathy, and to identify early markers of increased risk for the disease.

For further information, contact Dr. Chris Ketchum, Basic Renal Biology Program Director or Dr. Catherine Meyers, Inflammatory Kidney Diseases Program Director.

Resources for Researchers

Clinical Research


Committees and Advisory Groups

Related Study Sections


Funding Opportunities

Funding for Special Communities


Related Reports

Related Organizations

See Also

Page last updated: January 05, 2009

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation